Navigation Links
Glemser Announces New Labeling Solution: SPL for DCM Addresses New SPL Release 4 Requirements
Date:10/6/2008

Glemser Technologies, a Bethlehem, PA based pharmaceutical software and services company, today announced SPL for DCM, a new out-of-the-box labeling solution based on Documentum's Documentum Compliance Manager (DCM) application. SPL for DCM provides a complete labeling content management solution and addresses the SPL Release 4 submission standard mandated by the FDA, and represents the latest addition to Glemser's family of pharmaceutical labeling solutions.

Bethlehem, PA (PRWEB) October 6, 2008 -- Glemser Technologies, a Bethlehem, PA based pharmaceutical software and services company, today announced SPL for DCM, a new out-of-the-box labeling solution based on Documentum's Documentum Compliance Manager (DCM) application. SPL for DCM provides a complete labeling content management solution and addresses the SPL Release 4 submission standard mandated by the FDA, and represents the latest addition to Glemser's family of pharmaceutical labeling solutions.

Glemser's SPL for DCM solution is built on the Documentum 6.5 platform, and is implemented as a set of feature extensions and configurations of Documentum's DCM application. This architecture provides the benefit of DCM's proven, user-friendly application environment while delivering a complete set of features focused on managing package inserts and related labeling documentation. SPL for DCM also includes the ability to generate a complete SPL Release 4 submission file from content managed in the DCM environment. Like Glemser's other labeling solutions such as xmLabeling, the system also seamlessly integrates with either the PTC/Arbortext Epic or In.vision XML editors for creation and editing of content, and includes is pre-configured with the required document types and workflows to address labeling content processes.

According to Andrew Glemser, Chief Technology Officer of Glemser Technologies, "The exciting thing about SPL® for DCM is that it provides our clients the opportunity to implement a complete labeling and SPL Release 4 solution within the DCM application environment. DCM already provides a set of capabilities to address FDA regulatory requirements for controlled content, and SPL for DCM adds additional functionality directly targeted at the management of labeling content. The result is a seamless application environment that extends the range of the DCM platform."
SPL for DCM is scheduled for general release in December of this year.

About Glemser Technologies
Founded in 1987, Glemser designs and implements XML and content management solutions for life sciences companies. Glemser's solutions include xmLabeling, the leading content management solution for pharmaceutical labeling, which includes support for SPL and PIM. Glemser solutions allow pharmaceutical, consumer healthcare, medical device, and biotechnology companies to effectively address their research and development, regulatory affairs, manufacturing, quality assurance, and sales and marketing content management needs. For more information about Glemser Technologies and our other XML-based and SharePoint life sciences solutions, please visit us at www.glemser.com or contact us directly at inquiry@glemser.com.

Public Relations Contact:
Margaret Mottolo
Margaret.Mottolo @ glemser.com
781-995-0238

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1417584.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
2. Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners
3. Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
4. SyntheMed Announces New Management Appointments
5. Alba Therapeutics Corporation Announces Promotions
6. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
7. 23andMe Announces Breast Cancer Initiative
8. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
9. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2008 Results
10. Synthetech Announces New Director of Manufacturing
11. Micromet Announces Definitive Agreement for $40 Million Private Equity Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):